Dapoxetine 60 Pharmaqo: Compound Profile
Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) originally developed for premature ejaculation research applications. This short-acting compound demonstrates rapid onset and elimination kinetics in preclinical models, making it valuable for studying serotonin transport mechanisms and neural pathway modulation. Pharmaqo Labs produces these 60mg tablets for in-vitro laboratory research investigating neurotransmitter dynamics and receptor binding studies. Researchers at Stroid UK Shop utilise dapoxetine to examine serotonin reuptake inhibition patterns and associated pharmacokinetic profiles in controlled research environments.
Laboratory Research Applications
Research teams examine dapoxetine’s selective inhibition of serotonin transporters (SERT) in neural tissue culture studies. The compound’s unique pharmacokinetic profile allows investigators to study rapid-onset SSRI mechanisms without prolonged tissue exposure effects observed with traditional antidepressants. Laboratories studying erection drug mechanisms investigate how dapoxetine modulates serotonergic pathways involved in ejaculatory reflex control. Studies focus on the compound’s effects on spinal ejaculatory centres and brain stem nuclei responsible for ejaculatory timing. Research protocols examine dapoxetine’s interaction with 5-HT2C and 5-HT1A receptors in neural tissue samples. Additionally, researchers studying selective receptor modulators compare dapoxetine’s selectivity profile with other targeted compounds. Investigations into peptide signalling pathways often include dapoxetine as a control compound for serotonin-mediated effects on neuropeptide release.
Technical Specifications
| Chemical Name | (S)-N,N-Dimethyl-1-naphthalen-1-yl-3-phenylpropan-1-amine |
|---|---|
| CAS Number | 119356-77-3 |
| Molecular Formula | C21H23NO |
| Molecular Weight | 305.41 g/mol |
| Active Concentration | 60mg per tablet |
| Manufacturer | Pharmaqo Labs |
| Storage Conditions | Room temperature, dry environment, protect from light |
| Half-Life | Approximately 1.3 hours in research models |
Research Compliance Statement
Dapoxetine 60mg tablets are manufactured exclusively for laboratory research purposes and in-vitro studies. This product is not intended for human consumption, clinical application, or therapeutic use. Researchers must handle this compound in appropriate laboratory facilities with proper safety protocols and waste disposal procedures. All studies should comply with institutional review board guidelines and local regulations governing research chemical use. Laboratory personnel should maintain detailed research logs and ensure proper storage conditions to preserve compound integrity for experimental applications.
